Senior insider sale
President and CEO at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$11.58M
110K shares
What this filing means
MAINOLFI NELLO plans to sell 110K shares of KYMERA THERAPEUTICS, INC. valued at approximately $11.58M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/2/2026ACC: 0001969223-26-000752
DirectorOfficer· President and CEO
Since Aug 2020
110K
Shares to sell
$11.58M
Approx. market value
80K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of stock options
Cash
7/1/2026
80KTotal acquired80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of stock options Cash | 80K | — |
| Total | 80K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
30K
Market value
$2.44M
4/29/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
80K
Market value
$9.14M
7/1/2026
Total
Units
110K
Value
$11.58M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/29/2026 | 30K | $2.44M | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 80K | $9.14M | NASDAQ | Planned |
| Total | 110K | $11.58M | ||